Rothschild & Co Continuation
Finance PLC
Half-yearly Report for the six-month
period ended 30 June 2024
Interim Management Report
Summary of Important
Events
Rothschild & Co Continuation
Finance PLC (the "Company") is a wholly-owned subsidiary of N. M.
Rothschild & Sons Limited ("NMR") and was incorporated on 30
August 2000 to operate as a finance vehicle for the benefit of NMR
and its subsidiaries.
The principal activity of the
Company is the raising of finance for the purpose of lending it to
NMR and other companies in NMR's group (the "Group"). The Company
raises finance by the issue of perpetual subordinated notes
guaranteed by NMR.
Risks and Uncertainties
The principal risks of the Company
are credit risk, liquidity risk and market risk. The Company
follows the risk management policies of the parent undertaking,
NMR.
The Company's principal risk is
credit exposure to NMR, as the notes issued by the Company have
been guaranteed by, and funds have been on-lent to NMR. The Company
is therefore reliant on the ability of NMR to meet its obligations
under these lending arrangements. NMR is exposed to current market
and geopolitical headwinds but, nevertheless, has sufficient
liquidity to continue to operate for the next 12 months even in the
scenario where revenue is significantly reduced. Management has
considered the going concern basis of preparation as outlined in
note 1 to the financial statements.
This half-yearly financial report
has not been audited or reviewed by the Company's auditors pursuant
to the Auditing Practices Board guidance on Review of Interim
Financial Information.
Responsibilities
Statement
The Directors confirm that to the
best of their knowledge:
-
|
The condensed set of financial
statements has been prepared in accordance with IAS 34 Interim
Financial Reporting; and
|
-
|
The interim management report
includes a fair review of (i) the important events that have
occurred during the first six months of the financial year, and
their impact on the condensed set of financial statements, and (ii)
the principal risks and uncertainties for the remaining six months
of the financial year.
|
By Order of the Board
Peter Barbour
Director
18/07/2024
Condensed Interim Statement of
Comprehensive Income
For the six months ended 30 June
2024
|
|
6 months
to
|
6 months
to
|
|
|
30
June
2024
|
30
June
2023
|
|
Note
|
£
|
£
|
Interest income
|
|
2,128,839
|
2,053,754
|
Interest expense
|
|
(2,128,773)
|
(2,042,487)
|
Operating profit
|
|
66
|
11,267
|
Revaluation of loans
|
4
|
8,007,360
|
(3,476,570)
|
Revaluation of debt
securities
|
9
|
(8,011,889)
|
3,470,275
|
Foreign exchange translation
(losses)/gains
|
|
9,098
|
(7,337)
|
Profit/(loss) before tax
|
|
4,635
|
(2,365)
|
Taxation
|
3
|
(27)
|
(4,084)
|
Profit/(loss) for the financial period
|
|
4,608
|
(6,449)
|
Other comprehensive
income
|
|
-
|
-
|
Total comprehensive income/(loss) for the financial
period
|
|
4,608
|
(6,449)
|
Condensed Interim Statement of
Changes in Equity
For the six months ended 30 June
2024
|
Share
Capital
|
Retained
Earnings
|
Total
shareholders' equity
|
|
£
|
£
|
£
|
At 1 January 2024
|
100,000
|
317,636
|
417,636
|
Total comprehensive income for the
period
|
-
|
4,608
|
4,608
|
At 30 June 2024
|
100,000
|
322,244
|
422,244
|
|
|
|
|
At 1 January 2023
|
100,000
|
324,190
|
424,190
|
Total comprehensive loss for the
period
|
-
|
(6,449)
|
(6,449)
|
At 30 June 2023
|
100,000
|
317,741
|
417,741
|
Condensed Interim Balance
Sheet
At 30 June 2024
|
|
At 30
June
|
At 31
December
|
|
|
2024
|
2024
|
2023
|
2023
|
|
Note
|
£
|
£
|
£
|
£
|
Non-current assets
|
|
|
|
|
|
Loan to parent
undertaking
|
4
|
|
97,284,560
|
|
89,277,200
|
Current assets
|
|
|
|
|
|
Other financial assets
|
5
|
721,582
|
|
713,960
|
|
Cash and cash equivalents
|
6
|
267,050
|
|
268,360
|
|
|
|
988,632
|
|
982,320
|
|
Current liabilities
|
|
|
|
|
|
Current tax liability
|
|
(1,448)
|
|
(1,904)
|
|
Deferred tax liability
|
7
|
(46,327)
|
|
(45,844)
|
|
Other financial
liabilities
|
8
|
(709,155)
|
|
(712,007)
|
|
Net
current assets
|
|
|
231,702
|
|
222,565
|
Total assets less current liabilities
|
97,516,262
|
|
89,499,765
|
Non-current liabilities
|
|
|
|
|
|
Debt securities in issue
|
9
|
|
(97,094,018)
|
|
(89,082,129)
|
Net
assets
|
|
|
422,244
|
|
417,636
|
Shareholders' equity
|
|
|
|
|
|
Share capital
|
11
|
|
100,000
|
|
100,000
|
Retained earnings
|
|
|
322,244
|
|
317,636
|
Total shareholders' equity
|
|
|
422,244
|
|
417,636
|
Condensed Interim Cash Flow
Statement
For the six months ended 30 June
2024
|
|
6 months
to
|
6 months
to
|
|
|
30
June
2024
|
30
June
2023
|
|
Note
|
£
|
£
|
Cash flow from operating activities
|
|
|
|
Net profit/(loss) for the financial
period
|
|
4,608
|
(6,449)
|
Taxation
|
|
27
|
4,084
|
Net
cash inflow/(outflow) from operating activities
|
|
4,635
|
(2,365)
|
Cash flow from financing activities
Net increase/(decrease) in loans and
interest receivable
|
|
(8,014,982)
|
3,473,234
|
Net increase/(decrease) in debt
securities in issue and interest payable
|
|
8,009,037
|
(3,466,913)
|
Net
cash (outflow)/inflow from financing activities
|
|
(5,945)
|
6,321
|
Net
(decrease)/increase in cash and cash equivalents
|
|
(1,310)
|
3,956
|
Cash and cash equivalents at
beginning of half-year
|
|
268,360
|
265,057
|
Cash and cash equivalents at end of
half-year
|
6
|
267,050
|
269,013
|
Interest receipts and payments
during the period were as follows:
|
6 months
to
|
6 months
to
|
|
30 June
2024
|
30 June
2023
|
|
£
|
£
|
Interest received from parent
undertaking
|
2,121,217
|
2,050,418
|
Interest paid to note
holders
|
2,131,625
|
2,039,125
|
The Notes to the Condensed Interim
Financial Statements form an integral part of the Condensed Interim
Financial Statements.
Notes to the Condensed Interim
Financial Statements
(forming part of the Condensed Interim Financial
Statements)
For the six months ended 30 June
2024
1. Basis of
Preparation
The Condensed Interim Financial
Statements are prepared and approved by the Directors in accordance
with IAS 34 Interim Financial Reporting. The Condensed Interim
Financial Statements are prepared under the historical cost
accounting rules and should be read in conjunction with the annual
financial statements for the year ended 31 December 2023, which
have been prepared in accordance with International Financial
Reporting Standards.
The accounting policies and methods
of valuation are identical to those applied in the financial
statements for the year ended 31 December 2023.
Going Concern
Management has performed an
assessment to determine whether there are any material
uncertainties that could cast significant doubt on the ability of
the Company to continue as a going concern. No significant issues
have been noted. In reaching this conclusion, management
considered:
-
|
The financial impact of the
uncertainty on the Company's balance sheet;
|
-
|
The Company's liquidity position
based on current and projected cash resources. The liquidity
position has been assessed taking into account the forecast
liquidity of NMR and its ability to continue to pay the interest on
the intercompany loan provided by the Company.
|
Based on the above assessment of the
Company's financial position, the Directors have concluded that the
Company has adequate resources to continue in operational existence
for the foreseeable future (for a period of at least twelve months
after the date that the financial statements are signed).
Accordingly, they continue to adopt the going concern basis of
accounting in preparing the annual financial statements.
Financial Risk Management
The Company follows the financial
risk management policies of the parent undertaking, NMR. The
key risks arising from the Company's activities involving financial
instruments, which are monitored at the Group level, are as
follows:
-
|
Credit risk - the risk of loss
arising from client or counterparty default is not considered a
significant risk to the Company as all asset balances are with
other group companies as detailed in Note 12 Related Party
Transactions.
|
-
|
Market risk - exposure to changes in
market variables such as interest rates, currency exchange rates,
equity and debt prices is not considered significant as the terms
of financial assets substantially match those of financial
liabilities.
|
-
|
Liquidity risk - the risk that the
Company is unable to meet its obligations as they fall due or that
it is unable to fund its commitments is not considered significant
as the risk has been transferred to NMR. As the funds on-lent
to NMR have the same maturity dates as the notes issued, the
Company's ability to meet its obligations in respect of notes
issued by it is affected by NMR's ability to make payments to the
Company.
|
2. Directors'
Emoluments
None of the directors received any
remuneration in respect of their services to the Company during the
period (2023: £nil).
3. Taxation
|
6 months
to
30 June 2024
|
6 months
to
30 June
2023
|
|
£
|
£
|
Current tax
|
(1,159)
|
520
|
Deferred tax
|
1,132
|
(4,604)
|
Total tax
|
(27)
|
(4,084)
|
The tax charge can be explained as
follows:
|
6 months
to
|
6 months
to
|
|
30 June
2024
|
30 June
2023
|
|
£
|
£
|
Profit/(loss) before tax
|
4,635
|
(2,365)
|
United Kingdom corporation tax
credit/(charge) at effective rate 25%
|
(1,159)
|
520
|
Deferred tax income statement
charge
|
1,132
|
(4,604)
|
Tax charged for the
period
|
(27)
|
(4,084)
|
4. Non-Current Assets:
Loan to Parent Undertaking
|
At 30
June
|
At 31
December
|
|
2024
|
2023
|
|
£
|
£
|
At beginning of period
|
89,277,200
|
92,848,908
|
Fair value movements
|
8,007,360
|
(3,571,708)
|
At end of period
|
97,284,560
|
89,277,200
|
Due
|
|
|
In 5 years or more
|
97,284,560
|
89,277,200
|
IFRS 9 requires the €150,000,000
loan to be carried at fair value which as at 30 June 2024 was
£97,284,560 (at 31 December 2023: £89,277,200). On an amortised
cost basis, the value of the loan at 30 June 2024 would be
£127,028,217 (at 31 December 2023: £130,046,904). The fair values
are based on the market value of the external debt securities
(level 2).
The interest rate charged on the
€150 million loan is EUR-TEC10-CNO plus 36 basis points, capped at
9.01% fixed on 05 February, 05 May, 05 August and 05 November each
year. The interest rate on the above loan at 30 June 2024 was 3.41%
(31 December 2023: 3.66%).
5. Current Assets: Other
Financial Assets
|
At 30
June
|
At 31
December
|
|
2024
|
2023
|
|
£
|
£
|
Interest receivable
|
721,582
|
713,960
|
6. Cash and Cash
Equivalents
At 30 June 2024 the Company held
cash of £267,050 (31 December 2023: £268,360) at the parent
undertaking.
7. Deferred Income
Taxes
|
At 30
June
|
At 31
December
|
|
2024
|
2023
|
|
£
|
£
|
At beginning of period
|
(45,844)
|
(37,915)
|
Recognised in income:
Income statement charge
|
(483)
|
(7,929)
|
At end of period
|
(46,327)
|
(45,844)
|
Deferred tax assets less liabilities
are attributable to the following items:
|
At 30 June
2024
|
At 31
December 2023
|
|
£
|
£
|
Fair value of intra group
loans
|
7,435,914
|
9,580,879
|
Fair value of debt securities in
issue
|
(7,482,241)
|
(9,626,723)
|
|
(46,327)
|
(45,844)
|
Both
the intra-group loans and debt securities in issue are taxed on an
amortised cost basis of accounting and accordingly
taxable/deductible temporary differences arise following the
adoption of IFRS 9.
8. Current Liabilities:
Other Financial Liabilities
|
At 30
June
|
At 31
December
|
|
2024
|
2023
|
|
£
|
£
|
Interest payable
|
709,155
|
712,007
|
9. Non-Current
Liabilities: Debt Securities in Issue
|
At 30
June
|
At 31
December
|
|
2024
|
2023
|
|
£
|
£
|
At beginning of period
|
89,082,129
|
92,649,367
|
Fair value movements
|
8,011,889
|
(3,567,238)
|
At end of period
|
97,094,018
|
89,082,129
|
Due
|
|
|
In 5 years or more
|
97,094,018
|
89,082,129
|
Given the IFRS 9 requirement to fair
value the related loans, the Company has elected to fair value the
debt securities in issue, which as at 30 June 2024 was
£97,094,018 (at 31
December 2023: £89,082,129). On an amortised cost basis, the value
of the debt securities in issue at 30 June 2024 would be
£127,028,217 (at 31 December 2023: £130,046,904). Consistent with
the prior period, the fair value was derived from quoted market
prices at the balance sheet date. In accordance with IFRS 13 and
due to a reduction in the frequency and volume of transactions
observed in the immediate run up to the period end, the fair value
is considered to be level 2 as at 30 June 2024 (2023: level
2).
The interest rate payable on the
€150 million Perpetual Subordinated Notes is EUR-TEC10-CNO plus 35
basis points, capped at 9 per cent, fixed on 05 February, 05 May,
05 August and 05 November each year. From and including the
interest payment date falling in August 2016 and every interest
payment date thereafter, the Company may redeem all (i.e. not in
part) of the Perpetual Subordinated Notes at their principal
amount.
The interest rate on the above notes
at 30 June 2024 was 3.40% (31 December 2023: 3.65%).
10. Maturity of Financial
Liabilities
The following table shows
contractual cash flows payable by the Company on the perpetual
subordinated notes classified by remaining contractual maturity at
the balance sheet date. Interest cash flows on perpetual
subordinated notes are shown up to five years only, with the
principal balance being shown in the perpetual column.
At 30 June 2024
|
|
3
months
|
|
|
|
|
|
|
or
less
|
1
year
|
5
years
|
|
|
|
|
but
not
|
or
less
|
or
less
|
|
|
|
|
payable
on
|
but
over
|
but
over
|
|
|
|
Demand
|
demand
|
3
months
|
1
year
|
Perpetual
|
Total
|
|
£
|
£
|
£
|
£
|
£
|
£
|
Perpetual subordinated
notes
|
-
|
1,079,740
|
3,239,220
|
17,275,838
|
127,028,217
|
148,623,015
|
At 31 December 2023
|
|
3
months
|
|
|
|
|
|
|
or
less
|
1
year
|
5
years
|
|
|
|
|
but
not
|
or
less
|
or
less
|
|
|
|
|
payable
on
|
but
over
|
but
over
|
|
|
|
Demand
|
demand
|
3
months
|
1
year
|
Perpetual
|
Total
|
|
£
|
£
|
£
|
£
|
£
|
£
|
Perpetual subordinated
notes
|
-
|
1,186,678
|
3,560,034
|
18,986,848
|
130,046,904
|
153,780,464
|
11. Share
Capital
|
At 30
June
|
At 31
December
|
|
2024
|
2023
|
|
£
|
£
|
Authorised, allotted, called up and
fully paid
|
|
|
100,000 Ordinary shares of £1
each
|
100,000
|
100,000
|
12. Related Party
Transactions
Parties are considered to be related
if one party controls, is controlled by or has the ability to
exercise significant influence over the other party. This includes
key management personnel, the parent company, subsidiaries and
fellow subsidiaries.
Amounts receivable from related
parties at the period end were as follows:
|
At 30
June
|
At 31
December
|
|
2024
|
2023
|
|
£
|
£
|
Cash and cash equivalents at parent
undertaking
|
267,050
|
268,360
|
Accrued interest receivable from
parent undertaking
|
721,582
|
713,960
|
Loans to parent
undertaking
|
97,284,560
|
89,277,200
|
Amounts recognised in the condensed
statement of comprehensive income in respect of related party
transactions were as follows:
|
6 months
to
|
6 months
to
|
|
30 June
2024
|
30 June
2023
|
|
£
|
£
|
Interest income from parent
undertaking
|
2,128,839
|
2,053,754
|
There were no loans made to
Directors during the period (6 months to 30 June 2023: none) and no
balances outstanding at the period end (at 31 December 2023: £nil).
There were no employees of the Company during the period (6 months
to 30 June 2023: none).
13. Parent
Undertaking and Ultimate Holding Company and Registered
Office
The largest group in which the
results of the Company are consolidated is that headed by
Rothschild & Co Concordia SAS, incorporated in France, and
whose registered office is at 23bis, Avenue de Messine, 75008
Paris. The smallest group in which they are consolidated is
that headed by Rothschild & Co SCA, a French public limited
partnership whose registered office is also at 23bis, Avenue de
Messine, 75008 Paris. The accounts are available on the Rothschild
& Co website at www.rothschildandco.com.
The Company's immediate parent
company is N. M. Rothschild and Sons Limited, incorporated in
England and Wales and whose registered office is at New Court, St
Swithins Lane, London, EC7N 8AL.
The Company's registered office is
located at New Court, St Swithin's Lane, London, EC4N
8AL.